ALPS Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

ALPS Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-9,614	Closed	-$518K	–	1044
2017 Q4	$518K	Buy	9,614 +122	+1%	+$6.67K	﹤0.01%	521
2017 Q3	$542K	Buy	+9,492	New	+$556K	﹤0.01%	378

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

ALPS Advisors's BIVV Position: Q1 2018 in Review

ALPS Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 9,614 shares — an estimated $518K sold.

ALPS Advisors first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $542K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

ALPS Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
ALPS Advisors sold 9,614 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $518K.
ALPS Advisors first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
ALPS Advisors's Bioverativ Inc. Common Stock position peaked at $542K in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on ALPS Advisors's 13F filing for Q1 2018, filed 1 May 2018.